Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | ACLY | P53396 | 2/20 | 0.50 |
| ▸ | ACACA | Q13085 | 2/20 | 0.50 |
| ▸ | RELA | Q04206 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | XBP1 | P17861 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | SLC10A1 | Q14973 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.39 |
| ▸ | ELANE | P08246 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Gamma Oryzanol SCHEMBL23105398 | 1.00 | MEN1 (0.60) | MEN1KMT2AACLYACACARELA | |
| Gamma Oryzanol SCHEMBL29357024 | 1.00 | MEN1 (0.60) | MEN1KMT2AACLYACACARELA | |
| Gamma Oryzanol SCHEMBL21235210 | 1.00 | MEN1 (0.60) | MEN1KMT2AACLYACACARELA | |
| Gamma Oryzanol SCHEMBL12152368 | 1.00 | MEN1 (0.60) | MEN1KMT2AACLYACACARELA | |
| Gamma Oryzanol SCHEMBL29354302 | 1.00 | MEN1 (0.60) | MEN1KMT2AACLYACACARELA | |
| SCHEMBL10049046 | 0.94 | MEN1 (0.53) | MEN1KMT2AACLYACACARELA | |
| SCHEMBL31149054 | 0.94 | ACLY (0.52) | MEN1KMT2AACLYACACARELA | |
| SCHEMBL10017450 | 0.90 | MEN1 (0.51) | MEN1KMT2AACLYACACARELA | |
| SCHEMBL12152371 | 0.90 | MEN1 (0.63) | MEN1KMT2AACLYACACARELA | |
| SCHEMBL29524845 | 0.90 | MEN1 (0.63) | MEN1KMT2AACLYACACARELA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 413 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12385071-B2 | Methods for the production of ferulic acid | INVENTURE RENEWABLES, INC. (US) | 2025-08-12 | — | — | US | claimed |
| US-12342841-B2 | Compositions for improving low testosterone levels | CYTOSOLVE, INC. (US) | 2025-07-01 | — | — | US | claimed |
| CN-119894520-A | External skin preparation composition | 志瑞亚新药工业株式会社 | 2025-04-25 | — | — | CN | claimed |
| EP-4539853-A1 | HUMORAL IMMUNE ACTIVATORS FOR THE TREATMENT OF HUMORAL IMMUNOSUPPRESSED PATHOLOGIES, CANCER AND INFECTIOUS DISEASE AND HUMORAL IMMUNE SUPPRESSORS FOR THE TREATMENT OF INFLAMMATORY DISEASES | Navrogen, Inc. (US) | 2025-04-23 | — | — | EP | claimed |
| WO-2025063229-A1 | SKIN-IMPROVING AGENT | 第一三共ヘルスケア株式会社 | 2025-03-27 | — | — | WO | claimed |
| WO-2025063228-A1 | SKIN-IMPROVING AGENT | 第一三共ヘルスケア株式会社 | 2025-03-27 | — | — | WO | claimed |
| CN-119677519-A | Humoral immune activators for the treatment of humoral immune-suppressive pathologies, cancers and infectious diseases and humoral immune inhibitors for the treatment of inflammatory diseases | 纳夫罗根公司 | 2025-03-21 | — | — | CN | claimed |
| WO-2025048425-A1 | COMPOSITION FOR ALLEVIATING SKIN PIGMENTATION | 주식회사 엘지생활건강 | 2025-03-06 | — | — | WO | claimed |
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| EP-4404969-A1 | EXPANSION PROCESSES AND AGENTS FOR TUMOR INFILTRATING LYMPHOCYTES | Iovance Biotherapeutics, Inc. (US) | 2024-07-31 | — | — | EP | claimed |
| EP-4149438-A1 | SOLID ORAL COMPOSITIONS COMPRISING COMPOSITE MONOLITHIC MATRICES FOR CHRONOTROPIC ADMINISTRATION OF ACTIVE INGREDIENTS IN THE GASTROINTESTINAL TRACT | Mogon Pharmaceuticals Sagl (CH) | 2023-03-22 | — | — | EP | claimed |
| US-20230027119-A1 | METHODS FOR THE PRODUCTION OF FERULIC ACID | INVENTURE RENEWABLES INC (US) | 2023-01-26 | — | — | US | claimed |
| CN-111620775-B | Method for preparing cycloartenyl ferulate by selectively hydrolyzing oryzanol | 浙江得乐康食品股份有限公司 | 2023-01-10 | — | — | CN | claimed |
| WO-2022203145-A1 | LIPID NANOPARTICLE COMPOSITION PREPARED USING MASTIC GUM OR GAMMA ORYZANOL | 주식회사 앱스바이오 | 2022-09-29 | — | — | WO | claimed |
| WO-2022182527-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| US-20220273690-A1 | Edible Formulations Based on Active Ingredients and Arginine | GRAAL S R L (IT) | 2022-09-01 | — | — | US | claimed |
| EP-4021508-A1 | FORMULATIONS COMPRISING ARGININE AND/OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND AN ACID ACTIVE INGREDIENT WITH A PKA OF 1 -5 | Graal S.r.l. (IT) | 2022-07-06 | — | — | EP | claimed |
| US-20220117284-A1 | Compositions for Improving Low Testosterone Levels | CYTOSOLVE, INC. | 2022-04-21 | — | — | US | claimed |
| EP-3508471-B1 | METHOD FOR PRODUCING MICROPARTICLES FROM PRESSURIZED AND HEATED STARTING MATERIAL SOLUTION | M TECHNIQUE CO LTD (JP) | 2022-04-20 | — | — | EP | claimed |
| WO-2022036435-A1 | UNDERWEAR FOR DISPENSING THERAPEUTIC SUBSTANCES | SCOTT HILARY BRENDA (CA) | 2022-02-24 | — | — | WO | claimed |